The binding of NMO-IgG to AQP4 also reduces glutamine synthetase activity, an astrocytic enzyme that converts glutamate to glutamine, which participates in the local accumulation of glutamate [26]. The gene discussed is AQP4; the disease is neuromyelitis optica.